Sandro Pasquali, MD, PhD

Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardia, Italy

Disclosure information not submitted.

Presentation(s):

• Paper 37 - CINSARC IN PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA: COMBINED ANALYSIS OF EORTC-STBSG-62092 TRIAL (STRASS) AND SINGLE INSTITUTION DATA

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Paper 41 - REFINING THE CONTEMPORARY MANAGEMENT OF PRIMARY RETROPERITONEAL SARCOMA: SETTING NEW STANDARDS WAITING FOR NEW THERAPIES.

  Friday, November 15, 2024
  8:00 AM – 9:00 AM PST

• Session 9: Structural and Functional Omics

  Friday, November 15, 2024
  4:00 PM – 5:00 PM PST

• Paper 90 - FROM TARPSWG DEBUT TO THE RESAR DATABASE: STREAMLINING BACKOFFICE PROCESSES TO CENTRALIZE DATA AND FOSTER IMPROVED OUTCOMES IN RETROPERITONEAL SARCOMA

  Saturday, November 16, 2024
  1:00 PM – 2:00 PM PST

• Paper 104 - IMMUNOLOGICAL PROFILING OF PATIENTS WITH DESMOID FIBROMATOSIS UNDER ACTIVE SURVEILLANCE: RESULTS OF A LONGITUDINAL MONITORING IN A PROSPECTIVE TRIAL

  Saturday, November 16, 2024
  3:30 PM – 4:30 PM PST